Volume | 282,303 |
|
|||||
News | - | ||||||
Day High | 233.79 | Low High |
|||||
Day Low | 221.63 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Inspire Medical Systems Inc | INSP | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
233.15 | 221.63 | 233.79 | 223.14 | 231.74 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
9,237 | 282,303 | $ 225.89 | $ 63,770,215 | - | 123.27 - 330.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 37,501 | $ 223.14 | USD |
Inspire Medical Systems Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.6B | 29.59M | - | 624.8M | -21.15M | -0.72 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Inspire Medical Systems News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INSP Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 222.20 | 250.31 | 220.18 | 235.23 | 477,739 | 0.94 | 0.42% |
1 Month | 193.53 | 250.31 | 185.14 | 214.79 | 483,969 | 29.61 | 15.30% |
3 Months | 202.49 | 250.31 | 177.0675 | 204.09 | 485,160 | 20.65 | 10.20% |
6 Months | 150.03 | 250.31 | 123.27 | 177.26 | 613,822 | 73.11 | 48.73% |
1 Year | 260.27 | 330.00 | 123.27 | 211.22 | 567,254 | -37.13 | -14.27% |
3 Years | 228.04 | 330.00 | 123.27 | 213.89 | 370,728 | -4.90 | -2.15% |
5 Years | 57.83 | 330.00 | 40.53 | 172.99 | 346,093 | 165.31 | 285.86% |
Inspire Medical Systems Description
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States. |